gabexate has been researched along with Hemangioma in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Hemangioma: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, A | 1 |
| Tsukawaki, Y | 1 |
| Nioka, S | 1 |
| Yoda, K | 1 |
| Miyazaki, M | 1 |
| Kusaka, Y | 1 |
| Ban, S | 1 |
1 other study available for gabexate and Hemangioma
| Article | Year |
|---|---|
[Pre- and post-operative management of Kasabach-Merritt syndrome].
Topics: Blood Coagulation; Disseminated Intravascular Coagulation; Fibrous Dysplasia of Bone; Fibrous Dyspla | 1984 |